While most of the aforementioned checkpoints exert their major influence during T cell priming, other regulatory axes have been identified primarily regulating T cell activity directly within the tumor tissue including VISTA, PD-1, and the PD-1 ligands PD-L1 and PD-L2. The gene discussed is PDCD1; the disease is neoplasm.